Diabetes management system developer Diabeloop will use the funding from the Agir à dom and Air Liquide-backed round to accelerate growth.

Hui-Gene collected $14.2m from investors including WuXi AppTec and the Mayo Clinic-backed Huimei Healthcare Management to progress its gene therapy pipeline toward clinical testing and production.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Pharmaceutical research provider Tigermed co-led a round sized at nearly $71m for the cancer drug developer, which was spun off from Eddingpharm.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Cancer and autoimmune disease drug developer Clover Biopharmaceuticals has now raised in excess of $100m altogether, Jinrong Group backing its latest round.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Temasek has led a $220m funding round for PharmEasy, whose existing shareholders include Ascent Health and Wellness, Medi Assist and Manipal Education and Medical Group.

KU Leuven and Wellcome Trust will pilot a tech transfer scheme equipping early-stage scientific research with mentoring, prototyping and regulatory assistance.

USF and Florida Funders have tapped angel investment for a seed fund set to nurture research from Florida's public universities and the wider state ecosystem.